NSD2 and liver dysplastic nodule: Since NSD2 has been reported to participate in beta-cell proliferation and result in decreased glucose concentration [14], we therefore further treated the AAV-NSD2-treated mice with glucagon to evaluate whether the effect of NSD2 on DN is glucose-dependent.